Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Mammoth Bio CEO on Bayer Pact to Make Crispr Therapies
Posted
January 10, 2022
Views
3,248
Likes
92
Comments
11
Engagement
January 10, 2022
3,248
92
11
3.17%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:47Now PlayingMammoth Biosciences CEO Trevor Martin joins Emily Chang to discuss the company's latest partnership with Bayer to develop therapies and fortify its cell and gene therapy platform.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
